TITLE

The Other Diabetes

AUTHOR(S)
WALDEN, TIFFANY
PUB. DATE
November 2015
SOURCE
Ebony;Nov2015, Vol. 71 Issue 1, p76
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses Type 1 diabetes, also known as juvenile diabetes. Topics discussed include the American Diabetes Association (ADA) estimating 29 million U.S. residents living with some form of diabetes and a projection from the U.S. Census Bureau that minorities from lower-income families making up half of all type 1 cases by 2050. Also mentioned are descriptions of three main types of diabetes as well as the availability of a basal-bolus insulin injection regimen for diabetics.
ACCESSION #
110330962

 

Related Articles

  • 7. Approaches to Glycemic Treatment.  // Diabetes Care;2015 Supplement, Vol. 38, pS41 

    The article focuses on glycemic treatment approaches for type 1 diabetes patients according to the American Diabetes Association's Standards of Medical Care in Diabetes. Topics discussed include treatment with multiple-dose insulin (MDI) injections or continuous subcutaneous insulin infusion...

  • Combined Therapy with Insulin and Growth Hormone in 17 Patients with Type-1 Diabetes and Growth Disorders. Zucchini, Stefano; Iafusco, Dario; Vannelli, Silvia; Rabbone, Ivana; Salzano, Giuseppina; Pozzobon, Gabriella; Maghnie, Mohamad; Cherubini, Valentino; Bizzarri, Carla; Bonfanti, Riccardo; D'annunzio, Giuseppe; Lenzi, Lorenzo; Maggio, Maria Cristina; Marigliano, Marco; Scaramuzza, andrea; Tumini, Stefano; Iughetti, Lorenzo // Hormone Research in Paediatrics;Jul2014, Vol. 82 Issue 1, p53 

    Background/Aim: Combined growth hormone (GH) and insulin therapy is rarely prescribed by pediatric endocrinologists. We investigated the attitude of Italian physicians to prescribing that therapy in the case of short stature and type-1 diabetes (T1DM). Methods: A questionnaire was sent and if a...

  • Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Bruni, Anthony; Gala-Lopez, Boris; Pepper, Andrew R.; Abualhassan, Nasser S.; James Shapiro, A. M. // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;2014, Vol. 7, p211 

    Islet transplantation is a well-established therapeutic treatment for a subset of patients with complicated type I diabetes mellitus. Prior to the Edmonton Protocol, only 9% of the 267 islet transplant recipients since 1999 were insulin independent for .1 year. In 2000, the Edmonton group...

  • 11. Children and Adolescents.  // Diabetes Care;2015 Supplement, Vol. 38, pS70 

    The article focuses on the diagnosis, management and treatment of types 1 and 2 diabetes in children and adolescents according to the American Diabetes Association's Standards of Medical Care in Diabetes. Topics discussed include the impact of psychosocial issues and family stresses,...

  • Global Reality of Type 1 Diabetes Care in 2013. BERAN, DAVID; YUDKIN, JOHN S.; ATKINSON, MARK A. // Diabetes Care;Sep2013, Vol. 36 Issue 9, pe144 

    A letter to the editor is presented discussing type 1 diabetes care in 2013.

  • Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus. Ip Tim Lau; Ka Fai Lee; Wing Yee So; Tan, Kathryn; Vincent Tok Fai Yeung // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;Jun2017, Vol. 10, p273 

    Objective: To review published clinical studies on the efficacy and safety of new insulin glargine 300 units/mL (Gla-300), a new long-acting insulin analog, for the treatment of type 1 and type 2 diabetes mellitus (T1DM, T2DM). Materials and methods: Data sources comprised primary research...

  • Insulin Lispro Injection.  // AHFS Consumer Medication Information;Feb2020, p1 

    Insulin lispro is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and therefore...

  • Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial. Perkins, Bruce A.; Cherney, David Z. I.; Partridge, Helen; Soleymanlou, Nima; Tschirhart, Holly; Zinman, Bernard; Fagan, Nora M.; Kaspers, Stefan; Woerle, Hans-Juergen; Broedl, Uli C.; Johansen, Odd-Erik // Diabetes Care;May2014, Vol. 37 Issue 5, p1480 

    OBJECTIVE Adjunctive-to-insulin therapy with sodium-glucose cotransporter 2 (SGLT2) inhibition may improve glycemic control in type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS We evaluated the glycemic efficacy and safety of empagliflozin 25 mg daily in 40 patients treated for 8 weeks in a...

  • Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes. Dardano, Angela; Bianchi, Cristina; Del Prato, Stefano; Miccoli, Roberto // Vascular Health & Risk Management;2014, Vol. 10, p465 

    Glycemic control remains the major therapeutic objective to prevent or delay the onset and progression of complications related to diabetes mellitus. Insulin therapy represents a cornerstone in the treatment of diabetes and has been used widely for achieving glycemic goals. Nevertheless, a large...

  • Insulin Administration.  // Diabetes Care;Jan2003 Supplement, Vol. 26, pS121 

    Presents the 2003 position statement of the American Diabetes Association on insulin administration. Syringes; Syringe alternatives; Injection technique; Patient management.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics